Company intelligence
EMBALL'ISO
High performance temperature-controlled packaging systems / Expert of Reuse & Reverse Logistics
About EMBALL'ISO
A world leader in the design, manufacture, and validation of passive high-performance isothermal packaging for the transport of pharmaceutical products, EMBALL’ISO is also a pioneer and expert in Reuse and Reverse Logistics services for a Sustainable Cold Chain. In addition to the above-referenced services, EMBALL’ISO also offers complimentary support through their Metrology lab, Engineering team, Quality and Logistics teams, and a myriad of cutting-edge technologies available for applications such as AI modelling, simulation, chamber testing, 3D loading diagrams, lane risk assessments, predictive data analytics, and end-to-end real-time shipment visibility. EMBALL’ISO’s worldwide presence across 4 continents, with 12 manufacturing sites (USA, Brazil, France, Germany, England, India, Singapore, Mexico, China Japan & Vietnam), more than 15 additional Service Centers, and collection points in over 80 countries allows us to expedite global supply, recover, refurbish, and reuse our isothermal packaging, saving you time and money while ensuring compliance with your environmental sustainability goals.
Verified activity
Signals from EMBALL'ISO
5 published signals
Presence & Recognition
EMBALL'ISO is attending the The Pharma Logistics Masterclass in Frankfurt & Antwerp on September 14-17.
Reported by EMBALL'ISO
Presence & Recognition
EMBALL'ISO is attending the Ace Clinical Trials Supply Summit in London, UK on September 09-10.
Reported by EMBALL'ISO
Presence & Recognition
EMBALL'ISO is attending the Pharma.Aero Symposium in Brussels, Belgium on September 18.
Reported by EMBALL'ISO
Presence & Recognition
EMBALL'ISO is attending the PharmEDI VIETNAM event in Ho Chi Minh City on September 22-24.
Reported by EMBALL'ISO
Products & Services
EMBALL'ISO offers the Reuse & Reverse Logistics service for sustainable cold chain logistics, including collection, refurbishment, and repositioning.
Reported by EMBALL'ISO